As part of our commitment to develop the services and External Quality Assessment (EQA) programmes provided by this centre we are redesigning the Leukaemia Immunophenotyping (LI) programme to better reflect current hospital laboratory testing protocols. These changes are based on the format and findings from educational exercises A and B, previously issued within this programme.
For more information, please click on the link below.
To mark 50 years as World Leaders in EQA, UK NEQAS have organised a Pan-Disciplinary Scientific meeting ‘The Patient Behind the Sample’, to be held at The Helix in Dublin on Tuesday 5th November 2019. More information can be found in the flyer below or in the registration link here - http://www.sbk-healthcare.co.uk/home/title/2399/nhsconference/pan-disciplinary-uk-neqas-scientific-meeting-/
UK National External Quality Assessment Scheme for Leucocyte Immunophenotyping and Bio-Rad researchers will study ddPCR and RT-qPCR to determine whether ddPCR might be more suitable for monitoring CML treatment response.Please click here for more information.
For information on UK NEQAS LI services and the impact of Brexit, please read our official statement by clicking on the link below.
Sheffield Teaching Hospitals NHS Foundation Trust, a UKAS accredited proficiency testing provider No. 7804, operating UK NEQAS for Leucocyte Immunophenotyping.
You can find our schedule of accreditation here.
Also a link to the UKAS website is here.
UK NEQAS for Leucocyte Immunophenotyping (UK NEQAS LI) now has a Facebook page and a Twitter account. We will be posting important messages to these accounts relating to our schemes so please like or follow us, respectively.
We hope that these feeds will act as a useful eductational resource for participants and collaborators alike, collating interesting papers, conference info, videos and news stories in haemato-oncology. As we develop our online presence we hope to publish some of our own educational content. If you have any feedback or ideas as to content you would like us to include, please do not hesitate to get in touch.